Kevin Degeeter analyst LADENBURG

Currently out of the existing stock ratings of Kevin Degeeter, 105 are a BUY (95.45%), 5 are a HOLD (4.55%).

Kevin Degeeter

Work Performance Price Targets & Ratings Chart

Analyst Kevin Degeeter, currently employed at LADENBURG, carries an average stock price target met ratio of 49.97% that have a potential upside of 49.06% achieved within 311 days. Previously, Kevin Degeeter worked at OPPENHEIMER.

Kevin Degeeter’s has documented 208 price targets and ratings displayed on 38 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on NVCR, Novocure Ltd at 08-Jul-2025.

Wall Street Analyst Kevin Degeeter

Analyst best performing recommendations are on BNGO (BIONANO GENOMICS).
The best stock recommendation documented was for FLGT (FULGENT GENETICS) at 2/1/2021. The price target of $130 was fulfilled within 1 day with a profit of $7.91 (5.74%) receiving and performance score of 57.36.

Average potential price target upside

BNGO Bionano Genomics CYCC Cyclacel Pharmaceuticals DMTK DermTech EXAS EXACT Sciences FLGT Fulgent Genetics HGEN Humanigen INFI Infinity Pharmaceuticals IONS Ionis Pharmaceuticals MTEM Molecular Templates NVAX Novavax NVCR Novocure Ltd NVTA Invitae Corp OPK Opko Health ORIC Oric Pharmaceuticals  ORTX Orchard Therapeutics PLC PRTG Portage Biotech PSNL Personalis PTE Polarityte SNSE Sensei Biotherapeutics SPRO Spero Therapeutics VCEL Vericel Corp Ord ANTX AN2 Therapeutics CBIO Catalyst Biosciences CDTX Cidara Therapeutics IDYA Ideaya Biosciences KIN Kindred Biosciences MBRX Moleculin Biotech MDXH MDxHealth SA ADR SERA Sera Prognostics GHDX Genomic Health ADMA ADMA Biologics BTX Brooklyn Immunotherapeutics RCKT Rocket Pharmaceuticals CRDF Cardiff Oncology NVT nVent Electric PLC RZLT Rezolute TSHA Taysha Gene Therapies  VBLT Vascular Biogenics Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Apr-2025

$6

$4.84 (417.24%)

$7

Hold Since 28-Aug-2024

$4

$2.85 (247.83%)

$60

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Kevin Degeeter?

On 2011

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?